Stern J, Pier J, Litonjua AA. Asthma epidemiology and risk factors. Semin Immunopathol. 2020;42:5–15. https://doi.org/10.1007/s00281-020-00785-1

Article  PubMed  Google Scholar 

Ramírez-Marín HA, Silverberg JI. Differences between pediatric and adult atopic dermatitis. Pediatr Dermatol. 2022;39:345–53. https://doi.org/10.1111/pde.14971

Article  PubMed  Google Scholar 

Yaneva M, Darlenski R. The link between atopic dermatitis and asthma- immunological imbalance and beyond. Asthma Res Pract. 2021;7:16. https://doi.org/10.1186/s40733-021-00082-0

Article  PubMed  PubMed Central  Google Scholar 

Silva N, Carona C, Crespo C, Canavarro MC. Quality of life in pediatric asthma patients and their parents: a meta-analysis on 20 years of research. Expert Rev Pharmacoecon Outcomes Res. 2015;15:499–519. https://doi.org/10.1586/14737167.2015.1008459

Article  PubMed  Google Scholar 

Blome C, Radtke MA, Eissing L, Augustin M. Quality of life in patients with atopic dermatitis: disease burden, measurement, and treatment benefit. Am J Clin Dermatol. 2016;17:163–9. https://doi.org/10.1007/s40257-015-0171-3

Article  PubMed  Google Scholar 

Ali F, Vyas J, Finlay AY. Counting the burden: atopic dermatitis and health-related quality of life. Acta Derm Venereol. 2020;100:adv00161. https://doi.org/10.2340/00015555-3511

Article  PubMed  Google Scholar 

Eslambeik T, Pourvali A, Ghandi Y, Alaghmand A, Zamanian M, Tajerian A. Quality of life in children with asthma compared to healthy children: a case-control study. J Asthma. 2023;60:1942–50. https://doi.org/10.1080/02770903.2023.2200852

Article  CAS  PubMed  Google Scholar 

Kisieliene I, Mainelis A, Rudzeviciene O, Bylaite-Bucinskiene M, Wollenberg A. The burden of pediatric atopic dermatitis: quality of life of patients and their families. JCM. 2024. https://doi.org/10.3390/jcm13061700

Article  PubMed  PubMed Central  Google Scholar 

Yang EJ, Beck KM, Sekhon S, Bhutani T, Koo J. The impact of pediatric atopic dermatitis on families: a review. Pediatr Dermatol. 2019;36:66–71. https://doi.org/10.1111/pde.13727

Article  PubMed  Google Scholar 

Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Asthma – Langfassung, 4th ed. Version 1. 2020. https://doi.org/10.6101/AZQ/000469

Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32:657–82. https://doi.org/10.1111/jdv.14891

Article  CAS  PubMed  Google Scholar 

Agache I, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, et al. EAACI biologicals guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis. Allergy. 2021;76:988–1009. https://doi.org/10.1111/all.14690

Article  PubMed  Google Scholar 

Werfel T, Aberer W, Ahrens F, Augustin M, Biedermann T, Diepgen T, et al. S3-Leitlinie Atopische dermatitis (AD) [Neurodermitis; atopisches Ekzem]. Deutsche Dermatologische Gesellschaft e.V. (DDG); 2023.

Patel NU, D’Ambra V, Feldman SR. Increasing adherence with topical agents for atopic dermatitis. Am J Clin Dermatol. 2017;18:323–32. https://doi.org/10.1007/s40257-017-0261-5

Article  PubMed  Google Scholar 

Desager K, Vermeulen F, Bodart E. Adherence to asthma treatment in childhood and adolescence - a narrative literature review. Acta Clin Belg. 2018;73:348–55. https://doi.org/10.1080/17843286.2017.1409684

Article  PubMed  Google Scholar 

Conroy ER, Banzon TM, Simoneau T, Phipatanakul W, van Boven JFM, Larenas-Linnemann D. An overview of adherence-what it is and why it is important. J Allergy Clin Immunol Pract. 2024;12:3180–8. https://doi.org/10.1016/j.jaip.2024.07.018

Article  CAS  PubMed  Google Scholar 

Kosse RC, Bouvy ML, Daanen M, de Vries TW, Koster ES. Adolescents’ perspectives on atopic dermatitis treatment—experiences, preferences, and beliefs. JAMA Dermatol. 2018;154:824. https://doi.org/10.1001/jamadermatol.2018.1096

Article  PubMed  PubMed Central  Google Scholar 

Haktanir Abul M, Phipatanakul W. Severe asthma in children: evaluation and management. Allergol Int. 2019;68:150–7. https://doi.org/10.1016/j.alit.2018.11.007

Article  CAS  PubMed  Google Scholar 

Harb H, Chatila TA. Mechanisms of dupilumab. Clin Exp Allergy. 2020;50:5–14. https://doi.org/10.1111/cea.13491

Article  CAS  PubMed  Google Scholar 

Paller AS, Siegfried EC, Thaçi D, Wollenberg A, Cork MJ, Arkwright PD, et al. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial. J Am Acad Dermatol. 2020;83:1282–93. https://doi.org/10.1016/j.jaad.2020.06.054

Article  CAS  PubMed  Google Scholar 

Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, et al. Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial. JAMA Dermatol. 2020;156:44–56. https://doi.org/10.1001/jamadermatol.2019.3336

Article  PubMed  Google Scholar 

William W, Busse JF, Maspero, Klaus F, Rabe A, Papi SE, Wenzel LB, Ford, et al. Liberty asthma QUEST: phase 3 randomized, Double-Blind, Placebo-Controlled, Parallel-Group study to evaluate dupilumab efficacy/safety in patients with uncontrolled. Moderate-to-Severe Asthma: Adis Journals; 2018.

Google Scholar 

Wollenberg A, Marcoux D, Silverberg JI, Aoki V, Baselga E, Zhang H, et al. Dupilumab provides rapid and sustained improvement in scoring atopic dermatitis outcomes in paediatric patients with atopic dermatitis. Acta Derm Venereol. 2022;102:adv00726. https://doi.org/10.2340/actadv.v102.854

Article  CAS  PubMed  Google Scholar 

Fiocchi AG, Phipatanakul W, Zeiger RS, Durrani SR, Cole J, Msihid J, et al. Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study. Eur Respir J. 2023. https://doi.org/10.1183/13993003.00558-2023

Article  PubMed  PubMed Central  Google Scholar 

Ciprandi G, Licari A, Tosca MA, Del Miraglia Giudice M, Belloni Fortina A, Marseglia GL. An updated reappraisal of dupilumab in children and adolescents with moderate-severe atopic dermatitis. Pediatr Allergy Immunol. 2024;35:e14181. https://doi.org/10.1111/pai.14181

Article  CAS  PubMed  Google Scholar 

Paller AS, Silverberg JI, Simpson EL, Cork MJ, Arkwright PD, Chen Z, et al. The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study. J Am Acad Dermatol. 2025;92:116–26. https://doi.org/10.1016/j.jaad.2024.09.039

Article  CAS  PubMed  Google Scholar 

Dhar S, De A, Srinivas SM. Real-world effectiveness and safety of dupilumab for the treatment of moderate to severe atopic dermatitis in Indian patients: a multi centric retrospective study. Indian J Dermatol. 2021;66:297–301. https://doi.org/10.4103/ijd.ijd_860_20

Article  PubMed  PubMed Central  Google Scholar 

Yang D-Y, Li L, Lu T, Jing W-W, Liu X, Li X-L. Efficacy and safety of dupilumab in pediatric patients with moderate to severe atopic dermatitis: a real-world study. Arch Dermatol Res. 2023;315:467–72. https://doi.org/10.1007/s00403-022-02380-w

Article  CAS  PubMed  Google Scholar 

Patruno C, Fabbrocini G, Lauletta G, Boccaletti V, Colonna C, Cavalli R, et al. A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years. J Dermatolog Treat. 2023;34:2246602. https://doi.org/10.1080/09546634.2023.2246602

Article  CAS  PubMed  Google Scholar 

Napolitano M, Fabbrocini G, Potestio L, Fontanella G, Picone V, Bennardo L, et al. A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis. Dermatol Ther. 2022;35:e15588. https://doi.org/10.1111/dth.15588

Article  CAS  PubMed  Google Scholar 

Pagan AD, David E, Ungar B, Ghalili S, He H, Guttman-Yassky E. Dupilumab improves clinical scores in children and adolescents with moderate to severe atopic dermatitis: a real-world, single-center study. J Allergy Clin Immunol Pract. 2022;10:2378–85. https://doi.org/10.1016/j.jaip.2022.06.014

Article